Cytotoxicity and vitreous stability of chemically modified connexin43 mimetic peptides for the treatment of optic neuropathy

Journal of Pharmaceutical Sciences

Volumn 102, Issue 7, 2013, Pages 2322-2331

  Chen, Ying Shan ^a   Toth, Istvan ^b   Danesh Meyer, Helen V ^a   Green, Colin R ^a   Rupenthal, Ilva D ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cell culture; Conjugation; Connexin; HPLC; Intravitreal delivery; Lipoamino acid; Mimetic peptide; Peptide delivery; Solid phase peptide synthesis; Stability

Indexed keywords

AMINO ACID; CONNEXIN 43; PEPTIDOMIMETIC AGENT; SUGAR;

AREA UNDER THE CURVE; ARTICLE; ASTROCYTE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL VIABILITY; CHANNEL GATING; CHEMICAL MODIFICATION; CONTROLLED STUDY; COW; CYTOTOXICITY; DRUG CONJUGATION; DRUG HALF LIFE; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; MALE; NONHUMAN; OPTIC NERVE DISEASE; PEPTIDE SYNTHESIS; PHYSICAL CHEMISTRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE SYNTHESIS; VITREOUS BODY;

EID: 84879021391     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23617     Document Type: Article

References (45)

1. Kelsell DP, Dunlop J, Hodgins MB. 2001. Human diseases: Clues to cracking the connexin code? Trends Cell Biol 11(1):2-6.
2. Laird DW. 2006. Life cycle of connexins in health and disease. Biochem J 394(3):527-543.
3. Neijssen J, Pang B, Neefjes J. 2007. Gap junction-mediated intercellular communication in the immune system. Prog Biophys Mol Biol 94(1-2):207-218.
4. Grupcheva CN, Laux WT, Rupenthal ID, McGhee J, McGhee CNJ, Green CR. 2012. Improved corneal wound healing through modulation of gap junction communication using Connexin43-specific antisense oligodeoxynucleotides. Invest Ophthalmol Vis Sci 53(3):1130-1138.
5. Kerr NM, Johnson CS, de Souza CF, Chee KS, Good WR, Green CR, Danesh-Meyer HV. 2010. Immunolocalization of gap junction protein connexin43 (GJA1) in the human retina and optic nerve. Invest Ophthalmol Vis Sci 51(8):4028-4034.
6. Kerr NM, Johnson CS, Zhang J, Eady EK, Green CR, Danesh-Meyer HV. 2012. High pressure-induced retinal ischaemia reperfusion causes upregulation of gap junction protein connexin43 prior to retinal ganglion cell loss. Exp Neurol 234(1):144-152.
7. Chew SSL, Johnson CS, Green CR, Danesh-Meyer HV. 2011. Response of retinal Connexin43 to optic nerve injury. Invest Ophthalmol Vis Sci 52(6):3620-3629.
8. Cotrina ML, Kang J, Lin JH, Bueno E, Hansen TW, He L, Liu Y, Nedergaard M. 1998. Astrocytic gap junctions remain open during ischemic conditions. J Neurosci 18(7):2520-2537.
9. Danesh-Meyer HV, Kerr NM, Zhang J, Eady EK, O'Carroll SJ, Nicholson LFB, Johnson CS, Green CR. 2012. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain 135(2):506-520.
10. O'Carroll SJ, Alkadhi M, Nicholson LFB, Green CR. 2008. Connexin43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. Cell Commun Adhes 15:27-42.
11. Davidson JO, Green CR, B Nicholson LF, O'Carroll SJ, Fraser M, Bennet L, Jan Gunn A. 2012. Connexin hemichannel blockade improves outcomes in a model of fetal ischemia. Ann Neurol 71(1):121-132.
12. Blanchfield J, Toth I. 2004. Lipid, sugar and liposaccharide based delivery systems 2. Curr Med Chem 11:2375-2382.
13. Bergeon JA, Chan YN, Charles BG, Toth I. 2008. Oral absorption enhancement of dipeptide L-Glu-L-Trp-OH by lipid and glycosyl conjugation. Biopolymers 90(5):633-643.
14. Bergeon JA, Toth I. 2007. Enhancement of oral drug absorption-Effect of lipid conjugation on the enzymatic stability and intestinal permeability of l-Glu-l-Trp-NH2. Bioorg Med Chem 15(22):7048-7057.
15. Wong A, Toth I. 2001. Lipid, sugar and liposaccharide based delivery systems. Curr Med Chem 8:1123-1136.
16. Amon MA, Ali M, Bender V, Chan YN, Toth I, Manolios N. 2006. Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. Biochim Biophys Acta 1763(8):879-888.
17. Gibbons W, Hughes R, Charalambous M, Christodoulou M, Szeto A, Aulabaugh AE, Mascagni P, Toth I. 1990. Lipidic peptides, I. Synthesis, resolution and structural elucidation of lipidic amino acids and their homo- and hetero-oligomers. Liebigs Ann Chem 1990(12):1175-1183.
18. Toth I. 1994. A novel chemical approach to drug delivery: Lipidic amino acid conjugates. J Drug Target 2(3):217-239.
19. Kellam B, Drouillat B, Dekany G, Starr MS, Toth I. 1998. Synthesis and in vitro evaluation of lipoamino acid and carbohydrate-modified enkephalins as potential antinociceptive agents. Int J Pharm 161(1):55-64.
20. Flinn N, Coppard S, Toth I. 1996. Oral absorption studies of lipidic conjugates of thyrotropin releasing hormone (TRH)1 and luteinizing hormone-releasing hormone (LHRH). Int J Pharm 137(1):33-39.
21. Tomatis R, Marastoni M, Balboni G, Guerrini R, Capasso A, Sorrentino L, Santagada V, Caliendo G, Lazarus LH, Salvadori S. 1997. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides. J Med Chem 40(18):2948-2952.
22. Mizuma T, Ohta K, Awazu S. 1998. Intestinal absorption and analgesic activity of aminopeptidase-resistant cellobiose-coupled leucine enkephalinamide. Biopharm Drug Dispos 19(9):605-610.
23. Dhanasekaran M, Polt R. 2005. New prospects for glycopeptide based analgesia: Glycoside-induced penetration of the blood-brain barrier. Curr Drug Deliv 2(1):59-73.
24. Polt R, Dhanasekaran M, Keyari CM. 2005. Glycosylated neuropeptides: A new vista for neuropsychopharmacology? Med Res Rev 25(5):557-585.
25. Guo X, Geng M, Du G. 2005. Glucose transporter 1, distribution in the brain and in neural disorders: Its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem Genet 43(3):175-187.
26. Egleton RD, Mitchell SA, Huber JD, Palian MM, Polt R, Davis TP. 2001. Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation. J Pharmacol Exp Ther 299(3):967-972.
27. Vichai V, Kirtikara K. 2006. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1(3):1112-1116.
28. Evans WH, Leybaert L. 2007. Mimetic peptides as blockers of connexin channel-facilitated intercellular communication. Cell Commun Adhes 14(6):265-273.
29. Wang J, Li G, Wang Z, Zhang X, Yao L, Wang F, Liu S, Yin J, Ling EA, Wang L, Hao A. 2012. High glucose-induced expression of inflammatory cytokines and reactive oxygen species in cultured astrocytes. Neuroscience 202:58-68.
30. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, Feldman EL. 2002. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16(13):1738-1748.
31. Silver IA, Erecinska M. 1998. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons. J Neurophysiol 79(4):1733-1745.
32. DeVries SH, Schwartz EA. 1992. Hemi-gap-junction channels in solitary horizontal cells of the catfish retina. J Physiol 445(1):201-230.
33. Malchow R, Qian H, Ripps H. 1993. Evidence for hemi-gap junctional channels in isolated horizontal cells of the skate retina. J Neurosci Res 35(3):237-245.
34. Li H, Liu TF, Lazrak A, Peracchia C, Goldberg GS, Lampe PD, Johnson RG. 1996. Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells. J Cell Biol 134(4):1019-1030.
35. Braet K, Aspeslagh S, Vandamme W, Willecke K, Martin PEM, Evans WH, Leybaert L. 2003. Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1, 4, 5-trisphosphate and zero extracellular calcium in brain endothelial cells. J Cell Physiol 197(2):205-213.
36. Boitano S, Evans WH. 2000. Connexin mimetic peptides reversibly inhibit Ca2 +signaling through gap junctions in airway cells. Am J Physiol-Lung C 279(4):L623-L630.
37. John SA, Kondo R, Wang SY, Goldhaber JI, Weiss JN. 1999. Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem 274(1):236-240.
38. Hofer A, Dermietzel R. 1998. Visualization and functional blocking of gap junction hemichannels (connexons) with antibodies against external loop domains in astrocytes. Glia 24(1):141-154.
39. Stout C, Charles A. 2003. Modulation of intercellular calcium signaling in astrocytes by extracellular calcium and magnesium. Glia 43(3):265-273.
40. Leybaert L, Braet K, Vandamme W, Cabooter L, Martin PEM, Evans WH. 2003. Connexin channels, connexin mimetic peptides and ATP release. Cell Commun Adhes 10(4-6):251-257.
41. Evans WH, Boitano S. 2001. Connexin mimetic peptides: Specific inhibitors of gap-junctional intercellular communication. Biochem Soc Trans 29(Pt 4):606-612.
42. Evans WH, De Vuyst E, Leybaert L. 2006. The gap junction cellular internet: Connexin hemichannels enter the signalling limelight. Biochem J 397(Pt 1):1-14.
43. Muranushi N, Takagi N, Muranishi S, Sezaki H. 1981. Effect of fatty acids and monoglycerides on permeability of lipid bilayer. Chem Phys Lipids 28(3):269-279.
44. Toth I, Flinn N, Hillery A, Gibbons WA, Artursson P. 1994. Lipidic conjugates of luteinizing hormone releasing hormone (LHRH)+ and thyrotropin releasing hormone (TRH)+ that release and protect the native hormones in homogenates of human intestinal epithelial (Caco-2) cells. Int J Pharm 105(3):241-247.
45. Vannucci SJ, Maher F, Simpson IA. 1997. Glucose transporter proteins in brain: Delivery of glucose to neurons and glia. Glia 21(1):2-21.